277 related articles for article (PubMed ID: 21959128)
1. Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex.
Mori K; Mori T; Toda Y; Fujii E; Miyazaki M; Harada M; Kagami S
Brain Dev; 2012 Jun; 34(6):478-86. PubMed ID: 21959128
[TBL] [Abstract][Full Text] [Related]
2. High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI Instrument.
Taki MM; Harada M; Mori K; Kubo H; Nose A; Matsuda T; Nishitani H
Neuroimage; 2009 Oct; 47(4):1207-14. PubMed ID: 19481612
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance spectroscopy of tubers in patients with tuberous sclerosis.
Mizuno S; Takahashi Y; Kato Z; Goto H; Kondo N; Hoshi H
Acta Neurol Scand; 2000 Sep; 102(3):175-8. PubMed ID: 10987377
[TBL] [Abstract][Full Text] [Related]
4. Central-type benzodiazepine receptors and epileptogenesis: basic mechanisms and clinical validity.
Morimoto K; Tamagami H; Matsuda K
Epilepsia; 2005; 46 Suppl 5():184-8. PubMed ID: 15987275
[TBL] [Abstract][Full Text] [Related]
5. Decrease of the central type benzodiazepine receptor in cortical tubers in a patient with tuberous sclerosis.
Fujita M; Hashikawa K; Nagai T; Kodaka R; Uehara T; Nishimura T
Clin Nucl Med; 1997 Feb; 22(2):130-1. PubMed ID: 9031778
[No Abstract] [Full Text] [Related]
6. [Usefulness of 123I-iomazenil SPECT in pediatric patients with neurological disease].
Kuki I; Kawawaki H; Okazaki S; Inoue T; Nukui M; Tomiwa K; Amou K; Togawa M; Shiomi M
No To Hattatsu; 2012 Jan; 44(1):5-12. PubMed ID: 22352023
[TBL] [Abstract][Full Text] [Related]
7. Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex.
Mukonoweshuro W; Wilkinson ID; Griffiths PD
AJNR Am J Neuroradiol; 2001; 22(10):1920-5. PubMed ID: 11733326
[TBL] [Abstract][Full Text] [Related]
8. The correlation between 1H-MR spectroscopy and clinical manifestation with tuberous sclerosis complex.
Matsuo N; Imamura A; Ito R; Sugawara K; Takahashi Y; Kondo N
Neuropediatrics; 2007 Jun; 38(3):126-9. PubMed ID: 17985261
[TBL] [Abstract][Full Text] [Related]
9. Quantitative estimation of I-123-Iomazenil receptor binding in temporal lobe epilepsies using two SPECT acquisitions--comparison with the regional cerebral blood flow and a compartment model.
Venz S; Hierholzer J; Cordes M; Straub HB; Keske U; Meencke HJ; Eichstädt H; Felix R
Nuklearmedizin; 1998 Mar; 37(2):49-56. PubMed ID: 9547750
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of cerebral benzodiazepine receptor distribution in epilepsy by 123I-iomazenil-SPECT].
Uchiyama M; Sue H; Fukumitsu N; Mori Y; Kawakami K
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jan; 57(1):47-51. PubMed ID: 9038063
[TBL] [Abstract][Full Text] [Related]
11. Maturational Changes of Gamma-Aminobutyric Acid A Receptors Measured With Benzodiazepine Binding of Iodine 123 Iomazenil Single-Photon Emission Computed Tomography.
Ikemoto S; Hamano SI; Hirata Y; Matsuura R; Kikuchi K
Pediatr Neurol; 2018 May; 82():19-24. PubMed ID: 29625846
[TBL] [Abstract][Full Text] [Related]
12. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET.
Kaneko K; Sasaki M; Morioka T; Koga H; Abe K; Sawamoto H; Ohya N; Yoshiura T; Mihara F; Honda H
Nucl Med Commun; 2006 Nov; 27(11):893-9. PubMed ID: 17021430
[TBL] [Abstract][Full Text] [Related]
13. Neuroradiological and neurofunctional examinations for patients with 22q11.2 deletion.
Mori T; Mori K; Fujii E; Toda Y; Miyazaki M; Harada M; Kagami S
Neuropediatrics; 2011 Dec; 42(6):215-21. PubMed ID: 22131192
[TBL] [Abstract][Full Text] [Related]
14. Improved resolution of glutamate, glutamine and γ-aminobutyric acid with optimized point-resolved spectroscopy sequence timings for their simultaneous quantification at 9.4 T.
Dobberthien BJ; Tessier AG; Yahya A
NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29105187
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of the metabolites in the cortical masticatory area of patients with sleep bruxism: a magnetic resonance spectroscopy study].
Fan X; Wang J; Liu W
Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 May; 51(5):305-9. PubMed ID: 27220392
[TBL] [Abstract][Full Text] [Related]
16. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
[TBL] [Abstract][Full Text] [Related]
17. Decreased benzodiazepine receptor binding in Machado-Joseph disease.
Ishibashi M; Sakai T; Matsuishi T; Yonekura Y; Yamashita Y; Abe T; Ohnishi Y; Hayabuchi N
J Nucl Med; 1998 Sep; 39(9):1518-20. PubMed ID: 9744334
[TBL] [Abstract][Full Text] [Related]
18. A distinct microRNA expression profile is associated with α[
Bagla S; Cukovic D; Asano E; Sood S; Luat A; Chugani HT; Chugani DC; Dombkowski AA
Neurobiol Dis; 2018 Jan; 109(Pt A):76-87. PubMed ID: 28993242
[TBL] [Abstract][Full Text] [Related]
19. Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT.
Kugaya A; Sanacora G; Verhoeff NP; Fujita M; Mason GF; Seneca NM; Bozkurt A; Khan SA; Anand A; Degen K; Charney DS; Zoghbi SS; Baldwin RM; Seibyl JP; Innis RB
Biol Psychiatry; 2003 Oct; 54(8):792-9. PubMed ID: 14550678
[TBL] [Abstract][Full Text] [Related]
20. Validation of in vivo MRS measures of metabolite concentrations in the human brain.
Dhamala E; Abdelkefi I; Nguyen M; Hennessy TJ; Nadeau H; Near J
NMR Biomed; 2019 Mar; 32(3):e4058. PubMed ID: 30663818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
